Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients

BACKGROUND: Chronic liver disease and cirrhosis are of the major health concern worldwide. Assessment of liver fibrosis is necessary to determine disease severity and prognosis at the time of presentation to determine suitable treatment. Liver biopsy is considered as standard golden method in diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou Zaghla, Heba M. Adel, El Sebai, Aziza Ahmed, Ahmed, Ossama Ashraf, Ahmed, Ayat Fawzy, Saab, Azza Abdel Rahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814860/
https://www.ncbi.nlm.nih.gov/pubmed/34777864
http://dx.doi.org/10.1186/s43066-021-00075-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814860/
https://www.ncbi.nlm.nih.gov/pubmed/34777864
http://dx.doi.org/10.1186/s43066-021-00075-x

Ejemplares similares